Oncozenge AB (ONCOZ)

Currency in SEK
6.75
-0.16(-2.32%)
Real-time Data·
ONCOZ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.617.00
52 wk Range
4.5110.28
Key Statistics
Prev. Close
6.91
Open
7
Day's Range
6.61-7
52 wk Range
4.51-10.28
Volume
5.52K
Average Volume (3m)
38.06K
1-Year Change
2.4279%
Book Value / Share
0.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ONCOZ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Operates with a moderate level of debt

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
May 20, 2026
EPS / Forecast
-0.54 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ONCOZ Income Statement

Compare ONCOZ to Peers and Sector

Metrics to compare
ONCOZ
Peers
Sector
Relationship
P/E Ratio
−4.2x−2.9x−0.3x
PEG Ratio
0.02−0.040.00
Price/Book
271.2x0.0x2.6x
Price / LTM Sales
1,367.2x4.2x3.0x
Upside (Analyst Target)
66.4%199.9%56.3%
Fair Value Upside
Unlock33.6%9.8%Unlock

OncoZenge AB (publ), is a clinical-stage pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden. The company offers BupiZenge, which is in Phase 3 clinical trials for the treatment of pain in the oral cavity. The company was founded in 2020 and is headquartered in Bromma, Sweden.

Employees
1
Market
Sweden

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
5.55M39.48%37.71M
Public Companies & Retail Investors
8.50M60.52%57.82M
Total
14.05M100.00%95.53M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Linc AB8.33%1,170,6077,960
Svenska Mäklarkontoret Ab7.76%1,090,5007,415

FAQ

What Is the Oncozenge AB (ONCOZ) Stock Price Today?

The Oncozenge AB stock price today is 6.75 SEK.

What Stock Exchange Does Oncozenge AB Trade On?

Oncozenge AB is listed and trades on the Stockholm Stock Exchange.

What Is the Stock Symbol for Oncozenge AB?

The stock symbol for Oncozenge AB is "ONCOZ."

What Is the Oncozenge AB Market Cap?

As of today, Oncozenge AB market cap is 97.07M SEK.

What Is Oncozenge AB's Earnings Per Share (TTM)?

The Oncozenge AB EPS (TTM) is -1.85.

When Is the Next Oncozenge AB Earnings Date?

Oncozenge AB will release its next earnings report on Aug 27, 2026.

From a Technical Analysis Perspective, Is ONCOZ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Oncozenge AB Stock Split?

Oncozenge AB has split 0 times.

How Many Employees Does Oncozenge AB Have?

Oncozenge AB has 1 employees.

What is the current trading status of Oncozenge AB (ONCOZ)?

As of Jul 29, 2026, Oncozenge AB (ONCOZ) is trading at a price of 6.75 SEK, with a previous close of 6.91 SEK. The stock has fluctuated within a day range of 6.61 SEK to 7.00 SEK, while its 52-week range spans from 4.51 SEK to 10.28 SEK.

What Is Oncozenge AB (ONCOZ) Price Target According to Analysts?

The average 12-month price target for Oncozenge AB is 11.50 SEK, with a high estimate of 11.5 SEK and a low estimate of 11.5 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +70.37% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.